ADD-03055 is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs), particularly those targeting neurological disorders. Its structural properties make it suitable for modifying and enhancing the efficacy of drugs aimed at treating conditions such as Alzheimer's disease and Parkinson's disease. Additionally, ADD-03055 is employed in the development of novel therapeutic agents that require precise molecular configurations to achieve desired biological activities. Its role in streamlining the production process of complex drug molecules underscores its importance in advancing medical treatments.